tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LSTA Stock Latest News

Lisata Therapeutics’ Earnings Call: Progress Amid Challenges
Company AnnouncementsLisata Therapeutics’ Earnings Call: Progress Amid Challenges
3d ago
LSTA
Lisata Therapeutics Reports Positive Q3 2025 Results
PremiumCompany Announcements
Lisata Therapeutics Reports Positive Q3 2025 Results
4d ago
LSTA
Lisata Therapeutics Reports Q3 Results and Strategic Alliances
PremiumCompany Announcements
Lisata Therapeutics Reports Q3 Results and Strategic Alliances
4d ago
8K
LSTA
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
PremiumThe Fly
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
6d ago
LSTA
LSTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LSTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
LSTA
Lisata Therapeutics Highlights Cancer Therapy Innovations
PremiumCompany AnnouncementsLisata Therapeutics Highlights Cancer Therapy Innovations
27d ago
8K
LSTA
VTI ETF News, 10/10/2025
Premium
Market News
VTI ETF News, 10/10/2025
1M ago
LVO
VTI
Lisata Therapeutics Signs License Agreement with Catalent
Premium
Company Announcements
Lisata Therapeutics Signs License Agreement with Catalent
1M ago
8K
LSTA
Lisata Therapeutics, Catalent announce global ADC licensing agreement
PremiumThe Fly
Lisata Therapeutics, Catalent announce global ADC licensing agreement
1M ago
LSTA
Lisata Therapeutics announces results from pancreatic cancer cohort of CENDIFOX
PremiumThe Fly
Lisata Therapeutics announces results from pancreatic cancer cohort of CENDIFOX
1M ago
LSTA
Lisata Therapeutics: Promising Pipeline and Strong Financials Support Buy Rating
PremiumRatings
Lisata Therapeutics: Promising Pipeline and Strong Financials Support Buy Rating
3M ago
LSTA
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth
PremiumCompany Announcements
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth
3M ago
LSTA
Lisata Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsLisata Therapeutics Reports Q2 2025 Financial Results
3M ago
LSTA
Lisata Therapeutics Reports Strong Q2 2025 Financials
Premium
Company Announcements
Lisata Therapeutics Reports Strong Q2 2025 Financials
3M ago
8K
LSTA
Lisata Therapeutics, Inc. (LSTA) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Lisata Therapeutics, Inc. (LSTA) Q2 Earnings Cheat Sheet
3M ago
LSTA
Lisata Therapeutics, WARPNINE announce iLSTA trial enrollment completion
PremiumThe Fly
Lisata Therapeutics, WARPNINE announce iLSTA trial enrollment completion
4M ago
LSTA
Lisata Therapeutics announces preliminary data from iLSTA trial
PremiumThe Fly
Lisata Therapeutics announces preliminary data from iLSTA trial
4M ago
LSTA
Lisata Therapeutics price target raised to $32 from $20 at Brookline
PremiumThe Fly
Lisata Therapeutics price target raised to $32 from $20 at Brookline
4M ago
LSTA
Lisata Therapeutics Secures U.S. Patent for Certepetide
PremiumCompany Announcements
Lisata Therapeutics Secures U.S. Patent for Certepetide
4M ago
8K
LSTA
Lisata Therapeutics Reveals Promising Phase 2 Trial Data
PremiumCompany AnnouncementsLisata Therapeutics Reveals Promising Phase 2 Trial Data
5M ago
8K
LSTA
Lisata Therapeutics announces preliminary cohort B results from ASCEND trial
Premium
The Fly
Lisata Therapeutics announces preliminary cohort B results from ASCEND trial
5M ago
LSTA
Strategic Collaboration with GATC Health Boosts Lisata Therapeutics’ Growth Potential
Premium
Ratings
Strategic Collaboration with GATC Health Boosts Lisata Therapeutics’ Growth Potential
5M ago
LSTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >